Bonus Biogroup Ltd (BONS)

Bonus Biogroup will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Bonus Biogroup Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	10.23	11.18
Research & Development	17.61	18.61
Operating Expenses	27.84	29.79
Operating Income	-27.84	-29.79
Interest Expense / Income	-0.01	-1.26
Pretax Income	-27.83	-28.53
Net Income	-27.83	-28.53
Free Cash Flow	-21.72	-27.22
EBITDA	-25.04	-27.03
Depreciation & Amortization	2.79	2.76
EBIT	-27.84	-29.79

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).